Johnson & Johnson MedTech, a global leader in orthopedic technologies and solutions, announced today an exclusive commercial distribution agreement in the United States with Responsive Arthroscopy Inc., an innovative medical device company specializing in sports soft tissue repair solutions for the knee, hip, shoulder, foot and ankle. This strategic agreement strengthens Johnson & Johnson MedTech’s sports platform, enhancing its soft tissue portfolio to meet the rising demand for advanced solutions in the rapidly growing sports soft tissue repair market.
“Our relationship with Responsive Arthroscopy is a significant step in expanding our leadership in orthopedics and advancing our sports soft tissue offerings,” said Aldo Denti, Company Group Chairman, Orthopedics, Johnson & Johnson MedTech. “This collaboration allows us to deliver a broader range of cutting-edge tools that empower surgeons in shoulder, foot and ankle procedures. We’re excited to drive value in this rapidly growing segment and remain committed to advancing patient care in meaningful ways.”
By combining Johnson & Johnson MedTech’s expertise in orthopedic innovation with Responsive Arthroscopy’s advanced technologies, this agreement will provide healthcare providers with a more comprehensive set of tools to respond to evolving needs.
This collaboration marks a critical milestone in Johnson & Johnson MedTech’s mission to deliver innovative, impactful solutions that address evolving needs in orthopedics and elevate patient outcomes.
